Beneath the surface calm of rising broad indexes, a quiet but consequential repricing is underway in global equity markets — one that separates companies with genuine artificial intelligence exposure from those merely adjacent to the technology wave. Portfolio manager Darren Sissons, observing this rotation with the patience of someone who has watched markets reward and punish narratives before, sees in the current moment an opportunity for disciplined positioning. His three selections — Alphabet, McKesson, and Nestlé — reflect a philosophy that blends valuation discipline, structural defensiv
Sissons Favors Alphabet, McKesson, Nestlé Amid AI Rotation
The market is repricing technology based on AI exposure
Why does the rotation away from Meta and Microsoft matter if the overall market is hitting record highs?
Because index gains can mask what's actually happening underneath. The S&P 500 is up 21 percent, but that's being driven by a narrow set of stocks. If you own the wrong names—the ones the market has decided lack real AI exposure—you're not participating in those gains. You're treading water or going backward.
So this is about artificial intelligence becoming a prerequisite for growth stocks?
It's becoming the lens through which investors evaluate technology companies. If you're a software or cloud company and you can't articulate a credible AI strategy, the market is punishing you. That's a real shift from a year ago.
What makes Alphabet different from Meta or Microsoft in that regard?
Alphabet has been explicit about AI investment and has the cash flow to back it up. Its core advertising business is still strong, and it's using that to fund AI research. It's not betting the company on AI—it's using AI to strengthen what already works. Meta and Microsoft are perceived as more dependent on AI to justify their valuations.
McKesson seems like an odd pick in a tech-focused rotation.
It's not odd if you understand what Sissons is doing. He's not saying buy only AI stocks. He's saying the market is rotating, and that creates opportunities in overlooked sectors. McKesson is a defensive play—prescription drugs don't go out of fashion in a downturn. It's a ballast position.
And Nestlé?
Same logic. It's a dividend play for patient investors. The yield is real, the brands are durable, and the valuation is attractive. It's not exciting, but it's the kind of holding that lets you sleep at night while the market figures out which AI bets will actually pay off.
What's the risk in this positioning?
If the AI rotation reverses—if investors decide the hype has gotten ahead of reality—then the stocks Sissons is recommending could underperform again. And if the economy weakens faster than expected, even defensive names like McKesson could face pressure. But the bet here is that the rotation is real and has further to run.
Il Polso
- Celebrated tech giants like Meta and Microsoft are quietly losing ground even as the S&P 500 and Russell 2000 post impressive annual gains, revealing a market that rewards AI conviction and punishes its absence.
- The quarter's twin tailwinds — easing inflation and broadly positive corporate earnings — have created a deceptively stable surface beneath which capital is moving with real urgency.
- Sissons identifies Alphabet as a rare case of a world-class compounder trading near historical valuation lows, making it a high-conviction bet on AI infrastructure and advertising durability.
- McKesson's oligopolistic grip on pharmaceutical distribution and its steady capital return program offer a defensive anchor in a market increasingly prone to narrative-driven volatility.
- Nestlé, trading well below its long-term valuation averages and offering a 4.2% dividend yield amplified by Swiss franc strength, presents a patient investor's case for global consumer staples.
- Sissons's own track record from prior picks averaged just 1% total return, a candid reminder that even sound reasoning must contend with the market's unpredictable timing.
Beneath the surface calm of rising broad indexes, a quiet but consequential repricing is underway in global equity markets — one that separates companies with genuine artificial intelligence exposure from those merely adjacent to the technology wave. Portfolio manager Darren Sissons, observing this rotation with the patience of someone who has watched markets reward and punish narratives before, sees in the current moment an opportunity for disciplined positioning. His three selections — Alphabet, McKesson, and Nestlé — reflect a philosophy that blends valuation discipline, structural defensiveness, and the enduring power of essential goods, at a time when the market's enthusiasm is being redistributed rather than extinguished.
Darren Sissons of Campbell, Lee & Ross Investment Management is watching a market that looks calm from a distance but is quietly reshuffling beneath the surface. The S&P 500 and Russell 2000 have risen sharply over the past year, yet some of the most celebrated technology names are struggling — Meta down nearly 29 percent, Microsoft off almost 7 percent, Tesla barely moving. The rotation is clear to those watching individual stocks: capital is flowing toward companies with credible artificial intelligence exposure and away from those perceived as lacking it.
The quarter was shaped by declining inflation — aided by falling oil prices as Russia, the U.S., and China all increased crude supply — and broadly positive corporate earnings. Consumer resilience showed up in Visa's double-digit growth and New York City rents reaching a median of five thousand dollars per month, signals Sissons reads as evidence that financial stress has not yet spread beyond isolated pockets.
His three current picks reflect deliberate positioning across different risk profiles. Alphabet trades at 16.7 times forward earnings, far below its historical average of over 30 times, despite compounding earnings per share at 26 percent annually for a decade. Its advertising engine is now complemented by maturing cloud and subscription revenues, and management continues to invest heavily in AI infrastructure. McKesson, the largest pharmaceutical distributor in the United States, operates within a three-company oligopoly serving over a million healthcare providers. Its flat-fee procurement model generates stable revenue regardless of economic conditions, and a planned spin-off of its Medical-Surgical unit in mid-2027 adds a near-term catalyst. Nestlé rounds out the trio with a 4.2 percent dividend yield and a portfolio of enduring global brands — from Nescafé and Purina to KitKat and Perrier — currently trading well below its long-term valuation averages.
Sissons's prior recommendations averaged just 1 percent total return, a candid data point he does not obscure. His current message is straightforward: the market is actively repricing technology stocks along the axis of AI exposure, and investors who position ahead of that rotation — or who seek shelter in defensive compounders — are better placed than those holding technology names without meaningful AI credentials.
Darren Sissons, a portfolio manager at Campbell, Lee & Ross Investment Management, is watching the market make a quiet but significant shift. The broad indexes—the S&P 500 and Russell 2000—have climbed 21.75 percent and 34.75 percent respectively over the past year, yet beneath those gains lies a reshuffling that tells a different story. Some of the most celebrated technology companies are stumbling. Meta has fallen nearly 29 percent. Microsoft is down almost 7 percent. Tesla has barely moved, gaining just 3.55 percent. Meanwhile, investors are rotating capital toward companies with clear artificial intelligence exposure and away from those perceived as lacking it. The shift is subtle at the index level but unmistakable to those watching individual stocks.
The quarter that produced these moves was shaped by two broad forces: inflation continued its decline, helped along by falling oil prices as Russia and the United States increased crude exports and China drew down strategic reserves. At the same time, corporate earnings came in broadly positive or met expectations. Consumer spending remained resilient—Visa reported double-digit growth, and New York City rents climbed to a median of five thousand dollars per month, a marker Sissons reads as a sign that financial health on Wall Street has not yet curdled into widespread distress elsewhere in the economy.
Sissons sees opportunity in this moment, particularly for investors who bought into companies that had faced excessive pessimism about their AI prospects. His three top picks reflect a deliberate positioning: Alphabet, McKesson, and Nestlé. Alphabet trades at 16.7 times forward earnings, well below its historical average of 30.2 times and only slightly above its historical low of 19.1 times. The company has compounded earnings per share at 26 percent annually over the past decade. Advertising remains its engine, but subscriptions, platforms, and cloud services have matured into meaningful revenue streams. Management continues to invest heavily in artificial intelligence infrastructure. The company initiated a dividend in 2024 and now yields 0.25 percent.
McKesson represents a different kind of opportunity: defensive growth in a concentrated industry. As the largest pharmaceutical distributor in the United States, it operates within a three-company oligopoly with formidable barriers to entry. More than one million healthcare providers and fifty thousand pharmacies depend on its network. Ninety-five percent of its revenue flows through a stable, flat-fee procurement model that proves resilient regardless of economic conditions. The company has returned 17.5 percent annually in Canadian dollars over the past decade, while dividends have grown at 15 percent per year and share buybacks have reduced the share count by an average of 6 percent annually. McKesson plans to spin out its Medical-Surgical business through an initial public offering in mid-2027, with the unit valued at approximately thirteen billion dollars, or 11 percent of the company's current market capitalization. The stock yields 0.50 percent.
Nestlé offers the highest yield of the three at 4.2 percent, with dividends that have grown 6 percent annually in Canadian-dollar terms since 2016. The company owns a portfolio of global consumer staples that spans Nescafé coffee, Häagen-Dazs ice cream, Purina pet food, DiGiorno pizza, KitKat chocolate, Perrier water, and Starbucks Coffee At Home. Over the past decade, the dividend growth rate of 4 percent annually was amplified by a 29 percent appreciation of the Swiss franc against the Canadian dollar. The stock now trades 4 percent below its twenty-year average low valuation and 31 percent below its average high, suggesting room for revaluation.
Sissons's prior picks offer a mixed record. A year ago, he recommended Novo Nordisk at fifty-five dollars; it now trades at forty-six dollars, a loss of 12 percent including dividends. Tourmaline Oil, recommended at fifty-eight dollars, has climbed to sixty-two dollars, a 10 percent total return. Visa, at three hundred fifty-one dollars then, now sits at three hundred sixty-eight dollars, a 5 percent gain. The three picks averaged a 1 percent total return. The message embedded in his current selections is clear: the market is repricing technology stocks based on artificial intelligence exposure, and investors who position themselves ahead of that rotation stand to benefit. Those who hold technology names without meaningful AI credentials should exercise caution.
Citazioni salienti
Those who added exposure to names facing excessive AI pessimism performed strongly this quarter— Darren Sissons, Campbell, Lee & Ross Investment Management